MOBX Quote, Financials, Valuation and Earnings

AXT has a net margin of -390.56% compared to Mobix Labs's net margin of -12.42%. Mobix Labs's return on equity of -580.9% beat AXT's return on equity of -3.81%.

Mobix Labs has a consensus price target of --, signalling downside risk potential of --. On the other hand AXT has an analysts' consensus of -- which suggests that it could grow by 128.07%. Given that AXT has higher upside potential than Mobix Labs, analysts believe AXT is more attractive than Mobix Labs.

Mobix Labs has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison AXT has a beta of 2.150, suggesting its more volatile than the S&P 500 by 115.027%.

Mobix Labs has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. AXT offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Mobix Labs pays -- of its earnings as a dividend. AXT pays out -- of its earnings as a dividend.

Mobix Labs quarterly revenues are $3M, which are smaller than AXT quarterly revenues of $23.6M. Mobix Labs's net income of -$11.5M is lower than AXT's net income of -$2.9M. Notably, Mobix Labs's price-to-earnings ratio is -- while AXT's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Mobix Labs is 8.62x versus 1.04x for AXT. Usually stocks with elevated PS ratios are considered overvalued.

EMCORE has a net margin of -390.56% compared to Mobix Labs's net margin of -68.3%. Mobix Labs's return on equity of -580.9% beat EMCORE's return on equity of -91.56%.

Mobix Labs has a consensus price target of --, signalling downside risk potential of --. On the other hand EMCORE has an analysts' consensus of -- which suggests that it could grow by 2.31%. Given that EMCORE has higher upside potential than Mobix Labs, analysts believe EMCORE is more attractive than Mobix Labs.

Mobix Labs has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison EMCORE has a beta of 1.695, suggesting its more volatile than the S&P 500 by 69.479%.

Mobix Labs has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. EMCORE offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Mobix Labs pays -- of its earnings as a dividend. EMCORE pays out -- of its earnings as a dividend.

Mobix Labs quarterly revenues are $3M, which are smaller than EMCORE quarterly revenues of $20.4M. Mobix Labs's net income of -$11.5M is higher than EMCORE's net income of -$14M. Notably, Mobix Labs's price-to-earnings ratio is -- while EMCORE's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Mobix Labs is 8.62x versus 0.28x for EMCORE. Usually stocks with elevated PS ratios are considered overvalued.

Entegris has a net margin of -390.56% compared to Mobix Labs's net margin of 9.61%. Mobix Labs's return on equity of -580.9% beat Entegris's return on equity of 6.6%.

Mobix Labs has a consensus price target of --, signalling downside risk potential of --. On the other hand Entegris has an analysts' consensus of -- which suggests that it could grow by 27.85%. Given that Entegris has higher upside potential than Mobix Labs, analysts believe Entegris is more attractive than Mobix Labs.

Mobix Labs has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Entegris has a beta of 1.235, suggesting its more volatile than the S&P 500 by 23.523%.

Mobix Labs has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Entegris offers a yield of 0.39% to investors and pays a quarterly dividend of $0.10 per share. Mobix Labs pays -- of its earnings as a dividend. Entegris pays out 33.33% of its earnings as a dividend. Entegris's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Mobix Labs quarterly revenues are $3M, which are smaller than Entegris quarterly revenues of $807.7M. Mobix Labs's net income of -$11.5M is lower than Entegris's net income of $77.6M. Notably, Mobix Labs's price-to-earnings ratio is -- while Entegris's PE ratio is 67.40x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Mobix Labs is 8.62x versus 4.82x for Entegris. Usually stocks with elevated PS ratios are considered overvalued.

inTest has a net margin of -390.56% compared to Mobix Labs's net margin of 1.64%. Mobix Labs's return on equity of -580.9% beat inTest's return on equity of 2.9%.

Mobix Labs has a consensus price target of --, signalling downside risk potential of --. On the other hand inTest has an analysts' consensus of -- which suggests that it could grow by 31.73%. Given that inTest has higher upside potential than Mobix Labs, analysts believe inTest is more attractive than Mobix Labs.

Mobix Labs has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison inTest has a beta of 1.887, suggesting its more volatile than the S&P 500 by 88.712%.

Mobix Labs has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. inTest offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Mobix Labs pays -- of its earnings as a dividend. inTest pays out -- of its earnings as a dividend.

Mobix Labs quarterly revenues are $3M, which are smaller than inTest quarterly revenues of $30.3M. Mobix Labs's net income of -$11.5M is lower than inTest's net income of $495K. Notably, Mobix Labs's price-to-earnings ratio is -- while inTest's PE ratio is 39.68x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Mobix Labs is 8.62x versus 0.87x for inTest. Usually stocks with elevated PS ratios are considered overvalued.